Abstract:Objective: The Apelin/APJ system has recently been implicated in pathologies of hypertension. However, little was elucidated upon effects of Apelin on vascular adventitial remodeling progression. Here, we examined regulatory roles of Apelin in pressure overload-induced adventitial remodeling and fibrosis in hypertensive rats. Design and Method: The male Sprague–Dawley rats were performed with transverse aortic constriction (TAC). The rats with TAC were randomized to daily deliver either pyroglutamyl Apelin-13 (50 &mgr;g/kg) or saline for 4 weeks. Results: Histomorphometric analysis by HE and Masson trichrome staining revealed increased medial and adventitial thicknesses, especially in the adventitia, in ascending aortas in rats with TAC when compared with the sham-operated rats. Downregulation of APJ receptor and elevations in systolic blood pressure, phosphorylated mTOR and ERK1/2 levels were observed in hypertensive rats with TAC. Pressure overload-mediated by TAC led to marked increases in heart weight (HW), HW/body weight ratio, malonyldialdehyde (MDA) contents and aortic fibrosis in the hypertensive rats with enhanced activation of NADPH oxidase activity. The pressure overload-mediated pathological adventitial remodeling was strikingly rescued by Apelin-13 supplementation, associated with attenuation of aortic fibrosis and reduced mRNA expression of TGF-ß1 and collagen I. In cultured rat adventitial fibroblasts, exposure with Ang II (100 nmol L−1) resulted in obvious increases in MDA, phosphorylated levels of mTOR and ERK1/2 and mRNA levels of TGF-ß1, collagen I and fibronectin 1, which were dramatically prevented by Apelin-13 (100 nmol L−1) or mTOR inhibitor rapamycin (10 &mgr;mol L−1). However, Apelin-13 had no effect on collagen III levels. Conclusions: Our results demonstrate the importance of Apelin-13 in amelioration of aortic oxidative stress, adventitial remodeling and fibrosis in hypertensive rats with TAC via modulation of the mTOR/ERK signaling, thus indicating potential therapeutic strategies by enhancing Apelin/APJ action for preventing hypertensive vascular adventitial remodeling and fibrosis and pressure overload-associated cardiovascular disorders.

Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs

Angiotensin-(1-7) Mitigated Angiotensin II-induced Abdominal Aortic Aneurysms in Apolipoprotein E-knockout Mice.

Ascending Aortic Adventitial Remodeling and Fibrosis Are Ameliorated with Apelin-13 in Rats after TAC Via Suppression of the Mirna-122 and LGR4-β-catenin Signaling.

Protease Activated Receptor 2 Deficiency Retards Progression of Abdominal Aortic Aneurysms by Modulating Phenotypic Transformation of Vascular Smooth Muscle Cells Via ERK Signaling

Abstract 525: Angiotensin Ii Type 1a Receptor Deletion In Vascular Smooth Muscle Cells Prevent Abdominal Aortic Aneurysm Formation Induced By Angiotensin Ii Plus β-aminopropionitrile

Endothelial APLNR Regulates Tissue Fatty Acid Uptake and is Essential for Apelin's Glucose-Lowering Effects.

ADAM17: A novel treatment target for aneurysms

Pharmacological Inhibition of MMP-12 Exerts Protective Effects on Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice

Apelin/APJ System: A Novel Promising Therapy Target for Pathological Angiogenesis

Neutrophil Proteases Promote Experimental Abdominal Aortic Aneurysm via Extracellular Trap Release and Plasmacytoid Dendritic Cell Activation

Apelin–APJ Induces ICAM-1, VCAM-1 and MCP-1 Expression Via NF-κB/JNK Signal Pathway in Human Umbilical Vein Endothelial Cells

Apelin and APJ, a Novel Critical Factor and Therapeutic Target for Atherosclerosis.

Apelin prevents diabetes-induced poor collateral vessel formation and blood flow reperfusion in ischemic limb

OS 36-07 TREATMENT WITH APELIN-13 PREVENTS PRESSURE OVERLOAD-INDUCED AORTIC ADVENTITIAL REMODELING AND FIBROSIS IN HYPERTENSIVE RATS WITH TAC

PARP-1 (Poly[adp-Ribose] Polymerase 1) Inhibition Protects from Ang II (angiotensin II)–Induced Abdominal Aortic Aneurysm in Mice

Experimental aortic aneurysm severity and growth depend on topical elastase concentration and lysyl oxidase inhibition

Treatment With Apelin-13 Prevents Pressure Overload-Induced Aortic Adventitial Remodeling And Fibrosis In Hypertensive Rats With Tac

Matricellular Protein CCN3 Mitigates Abdominal Aortic Aneurysm

Transcriptome Analysis Reveals Therapeutic Potential of NAMPT in Protecting Against Abdominal Aortic Aneurysm in Human and Mouse

Abstract 057: Adenosine Kinase Epigenetically Regulates Abdominal Aortic Aneurysm Formation

ANGPTL8 deletion attenuates abdominal aortic aneurysm formation in ApoE-/- mice